COVID‐19‐Related Downscaling of In‐Hospital Liver Care Decreased Patient Satisfaction and Increased Liver‐Related Mortality
Lukas Hartl(Medical University of Vienna), Bernhard Scheiner(Medical University of Vienna), Katharina Pomej(Medical University of Vienna), Benedikt Simbrunner(Austrian Academy of Sciences), Matthias Pinter(Medical University of Vienna), Nawa Schirwani(Medical University of Vienna), Georg Semmler(University of Southern Denmark), Teresa Binter(Medical University of Vienna), Thomas Reiberger(ERN GUARD-Heart), Benedikt Hofer(Medical University of Vienna), Mathias Jachs(Medical University of Vienna), Mattias Mandorfer(Medical University of Vienna), Michael Trauner(Medical University of Vienna), David Bauer(Austrian Academy of Sciences)
Cited by 27
Related Papers
A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis
|New England Journal of Medicine|2016|1.1k
Efficacy of Obeticholic Acid in Patients With Primary Biliary Cirrhosis and Inadequate Response to Ursodeoxycholic Acid
|Gastroenterology|2014|563
Recent Insights into the Pathogenesis of Nonalcoholic Fatty Liver Disease
|Annual Review of Pathology Mechanisms of Disease|2018|561
Pathophysiological mechanisms of liver injury in COVID‐19
|Liver International|2020|399
Cancer and liver cirrhosis: implications on prognosis and management
|ESMO Open|2016|287